Topical ivermectin and encapsulated benzoyl peroxide work better than metronidazole for rosacea

A recent review published in the esteemed medical journal JAMA Dermatology has shed light on the most effective treatments for adults suffering from rosacea. The study, released online on July 1, compared the efficacy of topical ivermectin, encapsulated benzoyl peroxide, and metronidazole in treating this chronic skin condition. According to the findings, topical ivermectin and encapsulated benzoyl peroxide emerged as more effective treatments for adults with rosacea compared to metronidazole.

The review analyzed data from multiple clinical trials to evaluate the efficacy of these treatments in reducing symptoms of rosacea, including redness, inflammation, and acne-like lesions. Topical ivermectin, in particular, demonstrated significant improvements in reducing the severity of rosacea symptoms, while encapsulated benzoyl peroxide showed notable benefits in reducing inflammation and acne-like lesions. In contrast, metronidazole, a commonly prescribed antibiotic, was found to be less effective in treating rosacea symptoms.

The findings of this review provide valuable insights for healthcare professionals in treating adults with rosacea. The results suggest that topical ivermectin and encapsulated benzoyl peroxide may be more effective alternatives to metronidazole for managing this condition. Further research is needed to confirm these findings and to explore the optimal treatment strategies for rosacea patients.